{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:18:25Z","timestamp":1783163905529,"version":"3.54.6"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Deanship of Research and Graduate Studies at King Khalid University","award":["RGP1\/149\/46"],"award-info":[{"award-number":["RGP1\/149\/46"]}]},{"DOI":"10.13039\/100009526","name":"Amrita Vishwa Vidyapeetham University","doi-asserted-by":"publisher","award":["University Seed Grant"],"award-info":[{"award-number":["University Seed Grant"]}],"id":[{"id":"10.13039\/100009526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11535-0","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:28:54Z","timestamp":1775827734000},"page":"6339-6366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Network pharmacology, molecular docking, and In Vitro evaluation of morin against gastric cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Nilesh","family":"Naskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepanshu","family":"Mamgai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish Chandra","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar\u00a0Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-4497","authenticated-orcid":false,"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6682-3876","authenticated-orcid":false,"given":"Naseer","family":"Maliyakkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-8643","authenticated-orcid":false,"given":"Manish Kumar","family":"Jeengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"11535_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"11535_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5114\/pg.2018.80001","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A (2019) Epidemiology of gastric cancer: global trends, risk factors and prevention. Gastroenterol Rev 14:26\u201338. https:\/\/doi.org\/10.5114\/pg.2018.80001","journal-title":"Gastroenterol Rev"},{"key":"11535_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1468488","author":"T Zhang","year":"2024","unstructured":"Zhang T, Zhang Y, Leng X (2024) Global, regional, and national trends in gastric cancer burden: 1990\u20132021 and projections to 2040. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1468488","journal-title":"Front Oncol"},{"key":"11535_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.11622\/smedj.2014174","volume":"55","author":"T Ang","year":"2014","unstructured":"Ang T, Fock K (2014) Clinical epidemiology of gastric cancer. Singapore Med J 55:621\u2013628. https:\/\/doi.org\/10.11622\/smedj.2014174","journal-title":"Singapore Med J"},{"key":"11535_CR5","doi-asserted-by":"publisher","first-page":"116493","DOI":"10.1016\/j.bmc.2021.116493","volume":"51","author":"AR Bagheri","year":"2021","unstructured":"Bagheri AR, Aramesh N, Bilal M et al (2021) Carbon nanomaterials as emerging nanotherapeutic platforms to tackle the rising tide of cancer \u2013 a review. Bioorg Med Chem 51:116493. https:\/\/doi.org\/10.1016\/j.bmc.2021.116493","journal-title":"Bioorg Med Chem"},{"key":"11535_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"A Zafar","year":"2025","unstructured":"Zafar A, Khatoon S, Khan MJ et al (2025) Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Oncol 16:607. https:\/\/doi.org\/10.1007\/s12672-025-02198-8","journal-title":"Discov Oncol"},{"key":"11535_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","volume":"24","author":"M Zhang","year":"2025","unstructured":"Zhang M, Liu C, Tu J et al (2025) Advances in cancer immunotherapy: historical perspectives, current developments, and future directions. Mol Cancer 24:136. https:\/\/doi.org\/10.1186\/s12943-025-02305-x","journal-title":"Mol Cancer"},{"key":"11535_CR8","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-019-11622-x","volume":"10","author":"NP Bondonno","year":"2019","unstructured":"Bondonno NP, Dalgaard F, Kyr\u00f8 C et al (2019) Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort. Nat Commun 10:3651. https:\/\/doi.org\/10.1038\/s41467-019-11622-x","journal-title":"Nat Commun"},{"key":"11535_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/antiox8050137","volume":"8","author":"C Rodr\u00edguez-Garc\u00eda","year":"2019","unstructured":"Rodr\u00edguez-Garc\u00eda C, S\u00e1nchez-Quesada C, Gaforio JJ (2019) Dietary flavonoids as cancer chemopreventive agents: an updated review of human studies. Antioxidants (Basel) 8:137. https:\/\/doi.org\/10.3390\/antiox8050137","journal-title":"Antioxidants (Basel)"},{"key":"11535_CR10","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1080\/10408398.2017.1345853","volume":"58","author":"L Chen","year":"2018","unstructured":"Chen L, Teng H, Jia Z et al (2018) Intracellular signaling pathways of inflammation modulated by dietary flavonoids: the most recent evidence. Crit Rev Food Sci Nutr 58:2908\u20132924. https:\/\/doi.org\/10.1080\/10408398.2017.1345853","journal-title":"Crit Rev Food Sci Nutr"},{"key":"11535_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10068-021-00899-8","volume":"30","author":"Y Lee","year":"2021","unstructured":"Lee Y, Lee J, Lim C (2021) Anticancer activity of flavonoids accompanied by redox state modulation and the potential for a chemotherapeutic strategy. Food Sci Biotechnol 30:321\u2013340. https:\/\/doi.org\/10.1007\/s10068-021-00899-8","journal-title":"Food Sci Biotechnol"},{"key":"11535_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4196\/kjpp.2021.25.3.177","volume":"25","author":"GH Heeba","year":"2021","unstructured":"Heeba GH, Rabie EM, Abuzeid MM et al (2021) Morin alleviates fructose-induced metabolic syndrome in rats via ameliorating oxidative stress, inflammatory and fibrotic markers. Korean J Physiol Pharmacol 25:177\u2013187. https:\/\/doi.org\/10.4196\/kjpp.2021.25.3.177","journal-title":"Korean J Physiol Pharmacol"},{"key":"11535_CR13","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T et al (2021) PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res 49:D1388\u2013D1395. https:\/\/doi.org\/10.1093\/nar\/gkaa971","journal-title":"Nucleic Acids Res"},{"key":"11535_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.phcgj.2013.04.006","volume":"5","author":"J Venu Gopal","year":"2013","unstructured":"Venu Gopal J (2013) Morin hydrate: botanical origin, pharmacological activity and its applications: a mini-review. Pharmacogn J 5:123\u2013126. https:\/\/doi.org\/10.1016\/j.phcgj.2013.04.006","journal-title":"Pharmacogn J"},{"key":"11535_CR15","first-page":"1","volume-title":"Handbook of Dietary Flavonoids","author":"FF Lem","year":"2023","unstructured":"Lem FF, Jiunn Herng Lee D, Chee FT (2023) Pharmacological Insights into Morin: Therapeutic Applications and Future Perspectives. Handbook of Dietary Flavonoids. Springer International Publishing, Cham, pp 1\u201358"},{"key":"11535_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JBR-220032","volume":"12","author":"R Mondal","year":"2022","unstructured":"Mondal R, Antony S, Thriveni MC et al (2022) Genetic architecture of morin (pentahydroxyflavone) biosynthetic pathway in mulberry (Morus notabilis): an in silico approach. J Berry Res 12:483\u2013494. https:\/\/doi.org\/10.3233\/JBR-220032","journal-title":"J Berry Res"},{"key":"11535_CR17","doi-asserted-by":"publisher","first-page":"6843","DOI":"10.1002\/ptr.7270","volume":"35","author":"S Mottaghi","year":"2021","unstructured":"Mottaghi S, Abbaszadeh H (2021) The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: current status, challenges, and future perspectives. Phytother Res 35:6843\u20136861. https:\/\/doi.org\/10.1002\/ptr.7270","journal-title":"Phytother Res"},{"key":"11535_CR18","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1046\/j.1365-2036.2001.01133.x","volume":"15","author":"J G\u00e1lvez","year":"2001","unstructured":"G\u00e1lvez J, Coelho G, Crespo ME et al (2001) Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment Pharmacol Ther 15:2027\u20132039. https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01133.x","journal-title":"Aliment Pharmacol Ther"},{"key":"11535_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s13765-012-2110-9","volume":"55","author":"J-Y Yang","year":"2012","unstructured":"Yang J-Y, Lee H-S (2012) Evaluation of antioxidant and antibacterial activities of morin isolated from mulberry fruits (Morus alba L.). J Korean Soc Appl Biol Chem 55:485\u2013489. https:\/\/doi.org\/10.1007\/s13765-012-2110-9","journal-title":"J Korean Soc Appl Biol Chem"},{"key":"11535_CR20","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1016\/j.bbagen.2013.01.017","volume":"1830","author":"P Paoli","year":"2013","unstructured":"Paoli P, Cirri P, Caselli A et al (2013) The insulin-mimetic effect of Morin: a promising molecule in diabetes treatment. Biochimica et Biophysica Acta (BBA) - General Subjects 1830:3102\u20133111. https:\/\/doi.org\/10.1016\/j.bbagen.2013.01.017","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"11535_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jff.2019.01.052","volume":"55","author":"K Liang","year":"2019","unstructured":"Liang K, Kandhare AD, Mukherjee-Kandhare AA et al (2019) Morin ameliorates ovalbumin-induced allergic rhinitis via inhibition of STAT6\/SOCS1 and GATA3\/T-bet signaling pathway in BALB\/c mice. J Funct Foods 55:391\u2013401. https:\/\/doi.org\/10.1016\/j.jff.2019.01.052","journal-title":"J Funct Foods"},{"key":"11535_CR22","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.4110\/in.2020.20.e32","volume":"20","author":"E-H Hong","year":"2020","unstructured":"Hong E-H, Song J-H, Kim S-R et al (2020) Morin hydrate inhibits influenza virus entry into host cells and has anti-inflammatory effect in influenza-infected mice. Immune Netw 20:e32. https:\/\/doi.org\/10.4110\/in.2020.20.e32","journal-title":"Immune Netw"},{"key":"11535_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S2221-1691(12)60073-2","volume":"2","author":"P Prahalathan","year":"2012","unstructured":"Prahalathan P, Kumar S, Raja B (2012) Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study. Asian Pac J Trop Biomed 2:443\u2013448. https:\/\/doi.org\/10.1016\/S2221-1691(12)60073-2","journal-title":"Asian Pac J Trop Biomed"},{"key":"11535_CR24","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.prmcm.2023.100264","volume":"7","author":"VKR Balaga","year":"2023","unstructured":"Balaga VKR, Pradhan A, Thapa R et al (2023) Morin: a comprehensive review on its versatile biological activity and associated therapeutic potential in treating cancers. Pharmacol Res Mod Chin Med 7:100264. https:\/\/doi.org\/10.1016\/j.prmcm.2023.100264","journal-title":"Pharmacol Res Mod Chin Med"},{"key":"11535_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3892\/or.2021.8077","volume":"46","author":"K-S Lee","year":"2021","unstructured":"Lee K-S, Lee M-G, Nam K-S (2021) Evaluation of the antimetastatic and anticancer activities of morin in HER2-overexpressing breast cancer SK-BR-3 cells. Oncol Rep 46:126. https:\/\/doi.org\/10.3892\/or.2021.8077","journal-title":"Oncol Rep"},{"key":"11535_CR26","doi-asserted-by":"publisher","first-page":"102557","DOI":"10.1016\/j.tice.2024.102557","volume":"91","author":"F Fakhredini","year":"2024","unstructured":"Fakhredini F, Alidadi H, Mahdavinia M, Khorsandi L (2024) Morin promotes autophagy in human PC3 prostate cancer cells by modulating AMPK\/mTOR\/ULK1 signaling pathway. Tissue Cell 91:102557. https:\/\/doi.org\/10.1016\/j.tice.2024.102557","journal-title":"Tissue Cell"},{"key":"11535_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00404-018-4912-4","volume":"298","author":"D Bieg","year":"2018","unstructured":"Bieg D, Sypniewski D, Nowak E, Bednarek I (2018) Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Arch Gynecol Obstet 298:1181\u20131194. https:\/\/doi.org\/10.1007\/s00404-018-4912-4","journal-title":"Arch Gynecol Obstet"},{"key":"11535_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12272-019-01158-5","volume":"42","author":"YJ Lee","year":"2019","unstructured":"Lee YJ, Kim WI, Kim SY et al (2019) Flavonoid morin inhibits proliferation and induces apoptosis of melanoma cells by regulating reactive oxygen species, Sp1 and Mcl-1. Arch Pharm Res 42:531\u2013542. https:\/\/doi.org\/10.1007\/s12272-019-01158-5","journal-title":"Arch Pharm Res"},{"key":"11535_CR29","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2147\/DDDT.S360790","volume":"16","author":"J Gao","year":"2022","unstructured":"Gao J, Yang S, Xie G et al (2022) Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of aloin against gastric cancer. Drug Des Devel Ther 16:1947\u20131961. https:\/\/doi.org\/10.2147\/DDDT.S360790","journal-title":"Drug Des Devel Ther"},{"key":"11535_CR30","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.2147\/DDDT.S270757","volume":"14","author":"Y Huang","year":"2020","unstructured":"Huang Y, Lin J, Yi W et al (2020) Research on the potential mechanism of gentiopicroside against gastric cancer based on network pharmacology. Drug Des Devel Ther 14:5109\u20135118. https:\/\/doi.org\/10.2147\/DDDT.S270757","journal-title":"Drug Des Devel Ther"},{"key":"11535_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2311486","volume":"2021","author":"Y Qu","year":"2021","unstructured":"Qu Y, Yang X, Li J et al (2021) Network pharmacology and molecular docking study of Zhishi-Baizhu herb pair in the treatment of gastric cancer. Evid Based Complement Alternat Med 2021:1\u201318. https:\/\/doi.org\/10.1155\/2021\/2311486","journal-title":"Evid Based Complement Alternat Med"},{"key":"11535_CR32","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.2147\/JIR.S493892","volume":"17","author":"B Li","year":"2024","unstructured":"Li B, Liu J, He C et al (2024) Unveiling the therapeutic potential of berberine in rheumatoid arthritis: a comprehensive study of network pharmacology, metabolomics, and intestinal Flora. J Inflamm Res 17:10849\u201310869. https:\/\/doi.org\/10.2147\/JIR.S493892","journal-title":"J Inflamm Res"},{"key":"11535_CR33","unstructured":"What is considered a good GlideScore? https:\/\/my.schrodinger.com\/support\/article\/639. Accessed 24 Nov 2025"},{"key":"11535_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11030-024-10829-5","volume":"29","author":"N Dagar","year":"2025","unstructured":"Dagar N, Jadhav HR, Gaikwad AB (2025) Network pharmacology combined with molecular docking and dynamics to assess the synergism of esculetin and phloretin against acute kidney injury-diabetes comorbidity. Mol Divers 29:1\u201319. https:\/\/doi.org\/10.1007\/s11030-024-10829-5","journal-title":"Mol Divers"},{"key":"11535_CR35","doi-asserted-by":"publisher","first-page":"145555","DOI":"10.1016\/j.molstruc.2026.145555","volume":"1359","author":"S Gudasi","year":"2026","unstructured":"Gudasi S, Gharge S, Kumar D et al (2026) Comprehensive chemico-pharmacological profiling of Ailanthus excelsa Roxb bark: an integrated GC-MS\/MS and molecular dynamics approach with free energy landscape and PCA insights. J Mol Struct 1359:145555. https:\/\/doi.org\/10.1016\/j.molstruc.2026.145555","journal-title":"J Mol Struct"},{"key":"11535_CR36","doi-asserted-by":"crossref","unstructured":"David CC, Jacobs DJ (2014) Principal Component Analysis: A Method for Determining the Essential Dynamics of Proteins. pp 193\u2013226","DOI":"10.1007\/978-1-62703-658-0_11"},{"key":"11535_CR37","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1038\/s41598-025-34116-x","volume":"16","author":"SR Meghana","year":"2026","unstructured":"Meghana SR, Yogesh HS, Sangi SMA et al (2026) In-silico screening of marine fungal metabolites identifies potential FtsZ inhibitors against MDR-tuberculosis through docking and molecular dynamics analysis. Sci Rep 16:4030. https:\/\/doi.org\/10.1038\/s41598-025-34116-x","journal-title":"Sci Rep"},{"key":"11535_CR38","doi-asserted-by":"publisher","first-page":"e0310802","DOI":"10.1371\/journal.pone.0310802","volume":"19","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee NH, Hossain MdI, Priya FM et al (2024) Nature\u2019s defense against emerging neurodegenerative threats: dynamic simulation, PCA, DCCM identified potential plant-based antiviral lead targeting Borna disease virus nucleoprotein. PLoS ONE 19:e0310802. https:\/\/doi.org\/10.1371\/journal.pone.0310802","journal-title":"PLoS ONE"},{"key":"11535_CR39","doi-asserted-by":"publisher","first-page":"e02692","DOI":"10.1016\/j.sciaf.2025.e02692","volume":"28","author":"SH Abdullahi","year":"2025","unstructured":"Abdullahi SH, Patil RB, Uzairu A et al (2025) Unveiling novel VEGFR-2 inhibitors: QSAR modeling, molecular docking, MD and MM-GBSA calculations, pharmacokinetics profiling and DFT studies. Sci Afr 28:e02692. https:\/\/doi.org\/10.1016\/j.sciaf.2025.e02692","journal-title":"Sci Afr"},{"key":"11535_CR40","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/antibiotics10070856","volume":"10","author":"F Azam","year":"2021","unstructured":"Azam F (2021) Elucidation of Teicoplanin interactions with drug targets related to COVID-19. Antibiotics 10:856. https:\/\/doi.org\/10.3390\/antibiotics10070856","journal-title":"Antibiotics"},{"key":"11535_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/cancers14010102","volume":"14","author":"T Brew","year":"2021","unstructured":"Brew T, Bougen-Zhukov N, Mitchell W et al (2021) Loss of E-Cadherin leads to druggable vulnerabilities in sphingolipid metabolism and vesicle trafficking. Cancers (Basel) 14:102. https:\/\/doi.org\/10.3390\/cancers14010102","journal-title":"Cancers (Basel)"},{"key":"11535_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/biof.1315","volume":"43","author":"S Shrivastava","year":"2017","unstructured":"Shrivastava S, Jeengar MK, Thummuri D et al (2017) Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt\/\u03b2-catenin signaling cascades and reversal of epithelial\u2013mesenchymal transition. BioFactors 43:152\u2013169. https:\/\/doi.org\/10.1002\/biof.1315","journal-title":"BioFactors"},{"key":"11535_CR43","doi-asserted-by":"publisher","DOI":"10.32948\/ajo.2020.08.06","author":"M Kumar Jeengar","year":"2020","unstructured":"Kumar Jeengar M, Kumar S, Shrivastava S et al (2020) Niclosamide exerts anti-tumor activity through generation of reactive oxygen species and by suppression of Wnt\/ \u03b2-catenin signaling axis in HGC-27, MKN-74 human gastric cancer cells. Asia-Pacific J Oncol. https:\/\/doi.org\/10.32948\/ajo.2020.08.06","journal-title":"Asia-Pacific J Oncol"},{"issue":"3","key":"11535_CR44","doi-asserted-by":"publisher","first-page":"e13285","DOI":"10.1111\/jfbc.13285","volume":"45","author":"AJ Kammath","year":"2021","unstructured":"Kammath AJ, Nair B, Sreelekshmi P, Nath LR (2021) Curry versus cancer: Potential of some selected culinary spices against cancer with in vitro, in vivo, and human trials evidences. J Food Biochem 45(3):e13285. https:\/\/doi.org\/10.1111\/jfbc.13285","journal-title":"J Food Biochem"},{"key":"11535_CR45","doi-asserted-by":"publisher","first-page":"116251","DOI":"10.1016\/j.biopha.2024.116251","volume":"172","author":"A Pratas","year":"2024","unstructured":"Pratas A, Malh\u00e3o B, Palma R et al (2024) Effects of apigenin on gastric cancer cells. Biomed Pharmacother 172:116251. https:\/\/doi.org\/10.1016\/j.biopha.2024.116251","journal-title":"Biomed Pharmacother"},{"key":"11535_CR46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cbdd.13933","volume":"98","author":"Z Wang","year":"2021","unstructured":"Wang Z, Lv J, Li X, Lin Q (2021) The flavonoid Astragalin shows anti-tumor activity and inhibits PI3K\/AKT signaling in gastric cancer. Chem Biol Drug Des 98:779\u2013786. https:\/\/doi.org\/10.1111\/cbdd.13933","journal-title":"Chem Biol Drug Des"},{"key":"11535_CR47","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.18632\/oncotarget.6641","volume":"7","author":"W-L Fang","year":"2016","unstructured":"Fang W-L, Huang K-H, Lan Y-T et al (2016) Mutations in PI3K\/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers. Oncotarget 7:6201\u20136220. https:\/\/doi.org\/10.18632\/oncotarget.6641","journal-title":"Oncotarget"},{"key":"11535_CR48","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/cancers6031441","volume":"6","author":"T Matsuoka","year":"2014","unstructured":"Matsuoka T, Yashiro M (2014) The role of PI3K\/Akt\/mTOR signaling in gastric carcinoma. Cancers (Basel) 6:1441\u20131463. https:\/\/doi.org\/10.3390\/cancers6031441","journal-title":"Cancers (Basel)"},{"key":"11535_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/nu10081043","volume":"10","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Venkatarame Gowda Saralamma V, Kim SM et al (2018) Pectolinarigenin induced cell cycle arrest, autophagy, and apoptosis in gastric cancer cell via PI3K\/AKT\/mTOR signaling pathway. Nutrients 10:1043. https:\/\/doi.org\/10.3390\/nu10081043","journal-title":"Nutrients"},{"key":"11535_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2407-12-50","volume":"12","author":"J Shi","year":"2012","unstructured":"Shi J, Yao D, Liu W et al (2012) Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer. BMC Cancer 12:50. https:\/\/doi.org\/10.1186\/1471-2407-12-50","journal-title":"BMC Cancer"},{"key":"11535_CR51","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3892\/ijo.2015.3160","volume":"47","author":"P Khanna","year":"2015","unstructured":"Khanna P, Chua PJ, Bay BH, Baeg GH (2015) The JAK\/STAT signaling cascade in gastric carcinoma (Review). Int J Oncol 47:1617\u20131626. https:\/\/doi.org\/10.3892\/ijo.2015.3160","journal-title":"Int J Oncol"},{"key":"11535_CR52","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.3748\/wjg.v21.i10.2949","volume":"21","author":"Y Gong","year":"2015","unstructured":"Gong Y (2015) Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. World J Gastroenterol 21:2949. https:\/\/doi.org\/10.3748\/wjg.v21.i10.2949","journal-title":"World J Gastroenterol"},{"key":"11535_CR53","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/carcin\/bgy142","volume":"40","author":"Y Huang","year":"2019","unstructured":"Huang Y, Kang W, Ma Z et al (2019) NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K\/Akt\/mTOR signaling pathway. Carcinogenesis 40:370\u2013379. https:\/\/doi.org\/10.1093\/carcin\/bgy142","journal-title":"Carcinogenesis"},{"key":"11535_CR54","doi-asserted-by":"publisher","first-page":"119522","DOI":"10.1016\/j.lfs.2021.119522","volume":"278","author":"C Guo","year":"2021","unstructured":"Guo C, Chu H, Gong Z et al (2021) HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K\/AKT\/mTOR signaling pathway. Life Sci 278:119522. https:\/\/doi.org\/10.1016\/j.lfs.2021.119522","journal-title":"Life Sci"},{"key":"11535_CR55","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3390\/ijms25031848","volume":"25","author":"D-T Morgos","year":"2024","unstructured":"Morgos D-T, Stefani C, Miricescu D et al (2024) Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer. Int J Mol Sci 25:1848. https:\/\/doi.org\/10.3390\/ijms25031848","journal-title":"Int J Mol Sci"},{"key":"11535_CR56","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/tox.22623","volume":"33","author":"H Shang","year":"2018","unstructured":"Shang H, Lu H, Lee C et al (2018) Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol 33:1168\u20131181. https:\/\/doi.org\/10.1002\/tox.22623","journal-title":"Environ Toxicol"},{"key":"11535_CR57","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3390\/molecules26092802","volume":"26","author":"P-B Bhosale","year":"2021","unstructured":"Bhosale P-B, Vetrivel P, Ha S-E et al (2021) Iridin induces G2\/M phase cell cycle arrest and extrinsic apoptotic cell death through PI3K\/AKT signaling pathway in AGS gastric cancer cells. Molecules 26:2802. https:\/\/doi.org\/10.3390\/molecules26092802","journal-title":"Molecules"},{"key":"11535_CR58","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/ph14100973","volume":"14","author":"I Radziejewska","year":"2021","unstructured":"Radziejewska I, Supruniuk K, Czarnomysy R et al (2021) Anti-cancer potential of Afzelin towards AGS gastric cancer cells. Pharmaceuticals 14:973. https:\/\/doi.org\/10.3390\/ph14100973","journal-title":"Pharmaceuticals"},{"key":"11535_CR59","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6723","author":"S Wei","year":"2018","unstructured":"Wei S, Sun T, Du J et al (2018) Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2018.6723","journal-title":"Oncol Rep"},{"key":"11535_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2024.2313366","author":"J Liu","year":"2024","unstructured":"Liu J, Li S-M, Tang Y-J et al (2024) Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways. Redox Rep. https:\/\/doi.org\/10.1080\/13510002.2024.2313366","journal-title":"Redox Rep"},{"key":"11535_CR61","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/genes12071094","volume":"12","author":"C Cuesta","year":"2021","unstructured":"Cuesta C, Ar\u00e9valo-Alameda C, Castellano E (2021) The importance of being PI3K in the RAS signaling network. Genes 12:1094. https:\/\/doi.org\/10.3390\/genes12071094","journal-title":"Genes"},{"key":"11535_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1051\/vcm\/2024007","volume":"5","author":"X Li","year":"2024","unstructured":"Li X, Huang X, Chang M et al (2024) Updates on altered signaling pathways in tumor drug resistance. Visualized Cancer Med 5:6. https:\/\/doi.org\/10.1051\/vcm\/2024007","journal-title":"Visualized Cancer Med"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11535-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11535-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11535-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:39:14Z","timestamp":1783161554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11535-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11535"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11535-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7632832\/v1","asserted-by":"object"}]},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}